The results of Liu et al. (Liu L. et al., 2021) demonstrated that curcumin could decrease the expression of immune checkpoint ligands, such as PD-L1, PD-L2, and Galectin-9, in head and neck squamous cell carcinoma and affect tumor invasion by mediating EMT. Here, CD274 is linked to neoplasm.